This report contains market size and forecasts of Dolutegravir Sodium in global, including the following market information:
Global Dolutegravir Sodium Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dolutegravir Sodium Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Dolutegravir Sodium companies in 2021 (%)
The global Dolutegravir Sodium market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bottled Packaging Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dolutegravir Sodium include ViiV Healthcare UK, Emcure Pharmaceuticals, Aurobindo Pharma, LAURUS Labs, Mylan, Adcock Ingram Limited, Ranbaxy Pharmaceuticals and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dolutegravir Sodium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dolutegravir Sodium Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Dolutegravir Sodium Market Segment Percentages, by Type, 2021 (%)
Bottled Packaging
Film Coated Packaging
Global Dolutegravir Sodium Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Dolutegravir Sodium Market Segment Percentages, by Application, 2021 (%)
AIDS Adult Patients
AIDS Children over 12 Years Old
Global Dolutegravir Sodium Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Dolutegravir Sodium Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dolutegravir Sodium revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dolutegravir Sodium revenues share in global market, 2021 (%)
Key companies Dolutegravir Sodium sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Dolutegravir Sodium sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ViiV Healthcare UK
Emcure Pharmaceuticals
Aurobindo Pharma
LAURUS Labs
Mylan
Adcock Ingram Limited
Ranbaxy Pharmaceuticals
Cipla